Related Experiment Video
Updated: Aug 15, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
[Cardiovascular protection and prevention in patients with cardiac conditions and diabetes]
G Charpentier1, J Puel, P-G Steg
1Service de diabétologie, CH Sud Francilien, Corbeil (91). guillaume.charpentier@ch ncilien.fr
Insights
Maintaining good glycemic control is crucial for managing coronary artery disease, especially after myocardial infarction. Optimal treatment involves normalizing blood glucose and adhering to a four-drug regimen to improve patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Good glycemic control positively impacts coronary disease prognosis and reduces onset risk.
- Both postprandial and fasting blood glucose levels require normalization for cardiovascular health.
Purpose of the Study:
- To outline optimal treatment strategies for coronary patients, emphasizing glycemic control and risk factor reduction.
- To detail a four-drug regimen for managing coronary artery disease.
Main Methods:
- Review of existing literature on glycemic control and coronary heart disease management.
- Analysis of the role of specific drug classes in cardiovascular risk reduction.
- Emphasis on patient compliance as a key treatment objective.
Main Results:
- Effective beta-blocker therapy, low-dose aspirin (75-100 mg), statins for LDL-cholesterol reduction (<1 g/L), and ACE inhibitors are recommended.
- Normalization of both fasting and postprandial blood glucose is essential.
- Patient compliance significantly enhances treatment efficacy.
Conclusions:
- Optimal management of coronary artery disease necessitates strict glycemic control.
- A combination of risk factor reduction and a specific four-drug regimen improves patient outcomes.
- Achieving high patient compliance is paramount for effective treatment of coronary patients.
Abstract:
Good glycemic control can have a positive effect on the course and prognosis of coronary disease during and after myocardial infarction. It also reduces the risk of its onset. Both postprandial and fasting blood glucose must be normalized. Optimal treatment of coronary patients should include reduction of risk factors and 4 drugs: a beta-blocker at an effectively beta-blocking dose, aspirin at a daily dose between 75 and 100 mg, a statin that leads to an LDL-cholesterol level less than 1 g/L, and an angiotensin-converting enzyme inhibitor, with a demonstrated dose-effect relation. Efficacy is best when compliance is considered an essential objective.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications